WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
SRP-Funded Technology Provides Affordable PFAS Testing For Homeowners
Widespread chemical contamination leaves many small water systems without viable testing options.Discover how an innovative, plant-based extraction method delivers affordable, highly accurate screening to identify complex contaminants and protect public health.
-
The Enzyme Bottleneck: Why Conventional Lake Management Is Failing — And What The Science Says About Genuine Bio-Dredging For decades, the dominant framework for assessing and managing lake health has been built around surface water measurements: chlorophyll-a, total phosphorus, water clarity, and the composite Trophic State Index derived from them. These metrics are familiar, standardized, and widely accepted. They are also, according to a growing body of peer-reviewed literature, measuring the wrong part of the lake.
-
Ozone Off-Gas: What It Reveals About System Efficiency, Safety, and Design
Learn how ozone off-gas impacts system efficiency, safety, and performance, and why monitoring and management are critical for optimized water treatment operations.
-
UK Reservoirs, Water Shortages, And Legionella Risks Is there a clear link between a less plentiful water supply and an increase in Legionella in our domestic water systems?
-
The Devastating Legacy Of Algaecides: Why The Quick Fix Is Failing Our Lakes As warmer months approach, water management professionals must confront the compounding consequences of biocidal algae treatments.
-
What Is The Future Of Source Water Protection? Water utility managers and municipal leaders have long struggled amid the convergence of several threats to public water supplies. During a recent Water Online Live event, I sat with a panel of industry experts to examine the transition from reactive crisis management to a proactive, adaptive resilience framework.
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma
While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
This application note will explore how active control programs lower operational costs of compliant contaminant removal.
-
Hear from patients and caregivers across various therapeutic areas as they offer tips on improving the clinical trial experience.
-
An optimized in vitro transcription (IVT) platform enables scalable, high-yield, and cost-efficient mRNA therapeutic production by leveraging data-driven process optimization and enzyme innovation to overcome key manufacturing challenges.
-
As regulatory standards for PFAS become more stringent, specialized ion exchange resins provide a more efficient, high-capacity alternative to traditional carbon media, ultimately lowering long-term operational costs and improving overall system throughput and performance.
-
This resource will help you navigate the complexities of industrial and municipal wastewater treatment, understand the latest technology, and see how Aria Filtra® technology addresses the needs of modern wastewater management.
-
Managing PUPSIT‑related risks is a critical part of contamination control. Learn how bacterial retention studies, wetting fluids, and downstream practices influence sterility assurance.
-
Swan’s new Sample Filtration Cabinet delivers reliable orthophosphate monitoring, helping wastewater operators optimize chemical dosing, improve efficiency, and maintain regulatory compliance.
-
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Explore how ozone-based treatment supports data center water reuse by controlling biofilm, organics, metals, and microbial risks while reducing freshwater demand.
-
Precision medicine is opening new possibilities for IMIDs by moving beyond symptom‑based care. Find out how emerging multi‑omics tools are reshaping how these complex diseases are understood.
-
Discover common pitfalls in cell washing and pre-formulation, including incomplete contaminant removal, manual handling, and throughput issues that compromise product quality and efficiency.
-
Achieving compliance and safety through Disinfectant Efficacy Studies (DES) is about adhering to regulations and committing to high standards of safety and quality of manufacturing operations.
-
Precision inspection and compliance-driven processes are essential for manufacturing to help safeguard product quality, support regulatory requirements, and protect patient safety at scale.
-
Oxygen heterogeneity, caused by pressure variations and other factors in large-scale bioreactors, can significantly impact cell growth and product yield.
-
Discover how ion exchange technology effectively removes radioactive uranium isotopes from municipal wastewater. This case study explores the transition from pilot studies to full-scale remediation, highlighting the importance of technical support in meeting stringent local water quality standards.
-
Ozone and UV-AOP each offer powerful contaminant removal for drinking water, wastewater, and reuse applications. Their unique strengths—and potential synergy—help utilities meet diverse treatment goals efficiently.
-
Read this article for an overview of key advantages, as well as examples of how communities have achieved cost savings by moving towards above-ground systems.
-
Nitrosamines are a serious risk in drug products, driven by the presence of secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to risk mitigation and patient safety.